Study of BNT162b2 mRNA vaccine assessing age-related immune response heterogeneity to SARS-CoV-2 vaccine
Latest Information Update: 08 Sep 2021
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- 08 Sep 2021 New trial record
- 01 Aug 2021 Results published in the Nature